Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 27, 2022ARA-290Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0775-2022Class IITerminatedApr 27, 2022Rifampin for InjectionFailed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.Mylan Pharmaceuticals Inc · D-0774-2022Class IITerminatedApr 27, 2022Diclofenac Sodium Topical Solution 1.5% w/wCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0773-2022Class IITerminatedApr 20, 2022Econazole Nitrate CreamCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0771-2022Class IITerminatedApr 20, 2022Preferred PharmaceuticalsOut of specification results observed in dissolution during long term stability testing.Preferred Pharmaceuticals, Inc. · D-0769-2022Class IITerminatedApr 20, 2022Clobetasol Propionate Lotion 0.05%CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0768-2022Class IIITerminatedApr 20, 2022Cyanocobalamin InjectionSubpotent Drug: Out of Specification results for AssayAurobindo Pharma USA Inc. · D-0766-2022Class ITerminatedApr 20, 2022IDArubicin Hydrochloride Injection USP 5gm/5mLPresence of Particulate Matter: Product was found to contain silica and iron oxideTeva Pharmaceuticals USA Inc · D-0765-2022Class IIITerminatedApr 13, 2022Cequa (cyclosporine ophthalmic solution) 0.09%Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.Sun Pharmaceutical Industries Inc · D-0770-2022Class ITerminatedApr 13, 2022SYMJEPIDefective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.Adamis Pharmaceuticals Corporation · D-0764-2022Class ITerminatedApr 13, 2022SYMJEPIDefective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.Adamis Pharmaceuticals Corporation · D-0763-2022Class IIITerminatedApr 13, 2022Risedronate Sodium TabletsFAILED CONTENT UNIFORMITY SPECIFICATIONSMacleods Pharma Usa Inc · D-0762-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0761-2022Class IITerminatedApr 13, 2022quinapril HCl/hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0760-2022Class IITerminatedApr 13, 2022quinapril HCl/hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0759-2022Class IITerminatedApr 13, 2022quinapril and hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0758-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0757-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0756-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0755-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0754-2022Class IITerminatedApr 13, 2022Orphenadrine Citrate Extended-Release TabletsCGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.Sandoz, Inc · D-0753-2022Class IIITerminatedApr 13, 2022Methylprednisolone TabletsSubpotentJubilant Cadista Pharmaceuticals, Inc. · D-0752-2022Class IITerminatedApr 13, 2022The Natural Dentist Healthy Breath Antiseptic RinseLabeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Peppermint Oil and Sage Oil and has the wrong UPCRevive Personal Products Company · D-0751-2022Class IITerminatedApr 13, 2022Sucralfate Oral SuspensionLabeling: Label Mix-UpDASH Pharmaceuticals LLC · D-0749-2022Class IITerminatedApr 13, 2022Travoprost Ophthalmic SolutionSubpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related...Mylan Pharmaceuticals Inc · D-0748-2022Class IIITerminatedApr 13, 2022NETSPOTSubpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.Advanced Accelerator Applications USA, Inc. · D-0747-2022Class IITerminatedApr 13, 2022JanumetPresence of foreign substance: Presence of stainless steel particulates in tablets.Merck Sharp & Dohme Corp · D-0746-2022Class IIITerminatedApr 13, 202223.4% Sodium Chloride InjectionLabeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection...The Ritedose Corporation · D-0745-2022Class IITerminatedApr 13, 2022PHENOBARBITAL Sodium InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0744-2022Class IITerminatedApr 13, 2022PHENOBARBITAL Sodium InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0743-2022Class IITerminatedApr 13, 2022PAPAVERINE HYDROCHLORIDE InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0742-2022Class IITerminatedApr 13, 2022TETRACAINE 1% Tetracaine HCI InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0741-2022Class ITerminatedApr 6, 2022Meclizine Hydrochloride Tablets USPLabeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE...Jubilant Cadista Pharmaceuticals, Inc. · D-0767-2022Class IITerminatedApr 6, 2022Lansoprazole Delayed-Release CapsulesFailed Dissolution Specifications; during long term stability testing.Dr. Reddy's Laboratories, Inc. · D-0738-2022Class IITerminatedApr 6, 2022Lansoprazole Delayed-Release CapsulesFailed Dissolution Specifications; during long term stability testing.Dr. Reddy's Laboratories, Inc. · D-0737-2022Class IITerminatedApr 6, 2022Glycopyrrolate TabletsPresence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.Aurolife Pharma, LLC · D-0736-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE *GS*Lack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0735-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML InjectableLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0734-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE/PROPIONATE *SES* OilLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0733-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML InjectableLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0732-2022